Psychiatry and Neurology, Neurology · Knoxville, TN
NPI
1881662591
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2060 Lakeside Centre Way
Knoxville, TN, 37922
Phone (865) 218-6222
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
41,431 services
Medicare patients, 2024
218
Average age 66
Drug cost, 2024
$4.0M
2,776 prescriptions
Company payments, 2025
$113K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sibyl Wray was code J2350 (injection, ocrelizumab, 1 mg), 20,920 times for 19 patients. In total Sibyl Wray billed 41,431 services in 37 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2350 Injection, ocrelizumab, 1 mg | Office | 20,920 | 19 | $44.90 | $939K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,897 | 27 | $0.09 | $554 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,576 | 33 | $0.23 | $580 |
| 99214 Office E&M - Established | Office | 235 | 167 | $71.59 | $17K |
| 96127 Behavioral Health Services | Office | 171 | 101 | $0.01 | $1.57 |
| 96413 Chemotherapy Administration | Office | 157 | 52 | $75.11 | $12K |
| 96415 Chemotherapy Administration | Office | 113 | 43 | $16.82 | $1,900 |
| 99215 Office E&M - Established | Office | 91 | 78 | $117.88 | $11K |
| 96365 Intravenous Infusion, Hydration | Office | 72 | 49 | $38.26 | $2,755 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 53 | 40 | $1.87 | $99 |
| 99213 Office E&M - Established | Office | 16 | 16 | $49.63 | $794 |
| 81003 Clinical Chemistry | Office | 11 | 11 | $1.80 | $19.8 |
By year: 2022 $946K for 28,171 services; 2023 $1.2M for 36,923 services; 2024 $1.3M for 41,431 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 11 | 11 | $1.80 | $19.8 |
Medicare prescription drug claims, 2024
In 2024, the drug Sibyl Wray prescribed most often to Medicare patients was Baclofen, with 237 prescriptions and refills. In total Sibyl Wray wrote 2,776 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 237 | 450 | 57 | $4,506 |
| Tizanidine Hcl Generic | 163 | 339 | 37 | $2,575 |
| Gabapentin Generic | 138 | 249 | 42 | $2,344 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 108 | 119 | 27 | $3,501 |
| Diazepam Generic | 103 | 103 | 26 | $548 |
| Clonazepam Generic | 102 | 102 | 20 | $1,655 |
| Pregabalin Generic | 80 | 90 | 14 | $2,872 |
| Tramadol Hcl Generic | 75 | 75 | 14 | $775 |
| Duloxetine Hcl Generic | 69 | 193 | 19 | $2,021 |
| Bupropion Xl Bupropion Hcl | 67 | 137 | 16 | $2,109 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 65 | 69 | 15 | $2,829 |
| Kesimpta Pen Ofatumumab | 62 | 62 | Under 11 | $550K |
| Dalfampridine Er Dalfampridine | 57 | 79 | 12 | $45K |
| Aubagio Teriflunomide | 55 | 55 | Under 11 | $511K |
| Vumerity Diroximel Fumarate | 52 | 56 | Under 11 | $488K |
Brand drugs: - claims; generic drugs: 2,312 claims; opioid claims: 133.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sibyl Wray $113K ($10K in general payments such as food, travel and fees and $103K for research) from 22 companies. The largest payer was Genentech, Inc. with $64K.
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. ROG.SW | 15 | $64K |
| Amgen Inc. AMGN | 5 | $33K |
| TG Therapeutics, Inc. TGTX | 16 | $13K |
| Novartis Pharmaceuticals Corporation NVS | 4 | $1,991 |
| Biogen, Inc. BIIB | 10 | $287 |
| Genzyme Corporation SNY | 6 | $142 |
| Genentech USA, Inc. ROG.SW | 5 | $119 |
| Novartis Pharma AG NVS | 1 | $76.67 |
| CSL Behring CSL.AX | 2 | $56.98 |
| Cycle Pharmaceuticals Inc | 3 | $52.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.